Literature DB >> 15930067

Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective study.

Steven E Bruce1, Kimberly A Yonkers, Michael W Otto, Jane L Eisen, Risa B Weisberg, Maria Pagano, M Tracie Shea, Martin B Keller.   

Abstract

OBJECTIVE: The authors sought to observe the long-term clinical course of anxiety disorders over 12 years and to examine the influence of comorbid psychiatric disorders on recovery from or recurrence of panic disorder, generalized anxiety disorder, and social phobia.
METHOD: Data were drawn from the Harvard/Brown Anxiety Disorders Research Program, a prospective, naturalistic, longitudinal, multicenter study of adults with a current or past history of anxiety disorders. Probabilities of recovery and recurrence were calculated by using standard survival analysis methods. Proportional hazards regression analyses with time-varying covariates were conducted to determine risk ratios for possible comorbid psychiatric predictors of recovery and recurrence.
RESULTS: Survival analyses revealed an overall chronic course for the majority of the anxiety disorders. Social phobia had the smallest probability of recovery after 12 years of follow-up. Moreover, patients who had prospectively observed recovery from their intake anxiety disorder had a high probability of recurrence over the follow-up period. The overall clinical course was worsened by several comorbid psychiatric conditions, including major depression and alcohol and other substance use disorders, and by comorbidity of generalized anxiety disorder and panic disorder with agoraphobia.
CONCLUSIONS: These data depict the anxiety disorders as insidious, with a chronic clinical course, low rates of recovery, and relatively high probabilities of recurrence. The presence of particular comorbid psychiatric disorders significantly lowered the likelihood of recovery from anxiety disorders and increased the likelihood of their recurrence. The findings add to the understanding of the nosology and treatment of these disorders.

Entities:  

Mesh:

Year:  2005        PMID: 15930067      PMCID: PMC3272761          DOI: 10.1176/appi.ajp.162.6.1179

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  40 in total

1.  Panic disorder and cardiovascular/cerebrovascular problems: results from a community survey.

Authors:  M M Weissman; J S Markowitz; R Ouellette; S Greenwald; J P Kahn
Journal:  Am J Psychiatry       Date:  1990-11       Impact factor: 18.112

2.  Does cognitive-behavioural therapy influence the long-term outcome of generalized anxiety disorder? An 8-14 year follow-up of two clinical trials.

Authors:  R C Durham; J A Chambers; R R MacDonald; K G Power; K Major
Journal:  Psychol Med       Date:  2003-04       Impact factor: 7.723

3.  A 15-year follow-up study of patients with panic disorder.

Authors:  Sven Andersch; Jerker Hetta
Journal:  Eur Psychiatry       Date:  2003-12       Impact factor: 5.361

4.  The role of psychiatric disorders in predicting drug dependence treatment outcomes.

Authors:  Wilson M Compton; Linda B Cottler; Jacqueline L Jacobs; Arbi Ben-Abdallah; Edward L Spitznagel
Journal:  Am J Psychiatry       Date:  2003-05       Impact factor: 18.112

Review 5.  Anxiety states (anxiety neurosis): a review.

Authors:  I Marks; M Lader
Journal:  J Nerv Ment Dis       Date:  1973-01       Impact factor: 2.254

Review 6.  The natural history of anxiety disorders.

Authors:  J Angst; M Vollrath
Journal:  Acta Psychiatr Scand       Date:  1991-11       Impact factor: 6.392

7.  A follow-up study of DSM-III-R generalized anxiety disorder with syndromal and subsyndromal major depression.

Authors:  James G Barbee; Charles K Billings; Nancy B Bologna; Mark H Townsend
Journal:  J Affect Disord       Date:  2003-02       Impact factor: 4.839

8.  Clinical and psychosocial outcome of patients affected by panic disorder with or without agoraphobia: results from a naturalistic follow-up study.

Authors:  Bernardo Carpiniello; Antonella Baita; Mauro Giovanni Carta; Rossella Sitzia; Adolfo Maria Macciardi; Stefano Murgia; Alfredo Carlo Altamura
Journal:  Eur Psychiatry       Date:  2002-11       Impact factor: 5.361

9.  The phenomenology of panic attacks in panic disorder with and without agoraphobia.

Authors:  V Starcevic; R Kellner; E H Uhlenhuth; D Pathak
Journal:  Compr Psychiatry       Date:  1993 Jan-Feb       Impact factor: 3.735

10.  The Longitudinal Interval Follow-up Evaluation. A comprehensive method for assessing outcome in prospective longitudinal studies.

Authors:  M B Keller; P W Lavori; B Friedman; E Nielsen; J Endicott; P McDonald-Scott; N C Andreasen
Journal:  Arch Gen Psychiatry       Date:  1987-06
View more
  224 in total

1.  Comorbidity of generalized anxiety disorder and substance use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Analucía A Alegría; Deborah S Hasin; Edward V Nunes; Shang-Min Liu; Carrie Davies; Bridget F Grant; Carlos Blanco
Journal:  J Clin Psychiatry       Date:  2010-09       Impact factor: 4.384

2.  Impairment and functioning in a sample of primary care patients with generalized anxiety disorder: results from the primary care anxiety project.

Authors:  Risa B Weisberg; Courtney Beard; Maria E Pagano; Kristin M Maki; Larry Culpepper; Martin B Keller
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

Review 3.  Familial risk factors in social anxiety disorder: calling for a family-oriented approach for targeted prevention and early intervention.

Authors:  Susanne Knappe; Katja Beesdo-Baum; Hans-Ulrich Wittchen
Journal:  Eur Child Adolesc Psychiatry       Date:  2010-10-06       Impact factor: 4.785

4.  Anxiety and Substance Use Disorders: A Review.

Authors:  Joshua P Smith; Sarah W Book
Journal:  Psychiatr Times       Date:  2008-10

5.  Genetic and pharmacological manipulation of glyoxalase 1 regulates voluntary ethanol consumption in mice.

Authors:  Katherine M J McMurray; Preetpal S Sidhu; James M Cook; Leggy A Arnold; Abraham A Palmer
Journal:  Addict Biol       Date:  2015-12-22       Impact factor: 4.280

6.  Presence and Predictive Value of Obsessive-Compulsive Symptoms in Anxiety and Depressive Disorders.

Authors:  Mieke Klein Hofmeijer-Sevink; Neeltje M Batelaan; Harold J G M van Megen; Marcel A van den Hout; Brenda W Penninx; Anton J L M van Balkom; Danielle C Cath
Journal:  Can J Psychiatry       Date:  2017-05-16       Impact factor: 4.356

7.  Altered emotion regulation capacity in social phobia as a function of comorbidity.

Authors:  Lisa J Burklund; Michelle G Craske; Shelley E Taylor; Matthew D Lieberman
Journal:  Soc Cogn Affect Neurosci       Date:  2014-05-08       Impact factor: 3.436

Review 8.  Can Long-Term Pharmacotherapy Prevent Relapses in Generalized Anxiety Disorder? A Systematic Review.

Authors:  Marina Dyskant Mochcovitch; Rafael Christophe da Rocha Freire; Rafael Ferreira Garcia; Antonio Egidio Nardi
Journal:  Clin Drug Investig       Date:  2017-08       Impact factor: 2.859

9.  Two-year course of generalized anxiety disorder, social anxiety disorder, and panic disorder in a longitudinal sample of African American adults.

Authors:  Nicholas J Sibrava; Courtney Beard; Andri S Bjornsson; Ethan Moitra; Risa B Weisberg; Martin B Keller
Journal:  J Consult Clin Psychol       Date:  2013-09-16

10.  Gender differences in major depressive disorder: findings from the Singapore Mental Health Study.

Authors:  Louisa Picco; Mythily Subramaniam; Edimansyah Abdin; Janhavi Ajit Vaingankar; Siow Ann Chong
Journal:  Singapore Med J       Date:  2016-08-16       Impact factor: 1.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.